Literature DB >> 14748746

Targeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene ontology analysis.

Woong Shick Ahn1, Ko-Woon Kim, Su Mi Bae, Joo Hee Yoon, Joon Mo Lee, Sung Eun Namkoong, Jin Hong Kim, Chong Kook Kim, Young Joo Lee, Yong-Wan Kim.   

Abstract

This study utilized both cDNA microarray and two-dimensional protein gel electrophoresis technology to investigate the multiple interactions of genes and proteins involved in uterine leiomyoma pathophysiology. Also, the gene ontology analysis was used to systematically characterize the global expression profiles at cellular process levels. We profiled differentially expressed transcriptome and proteome in six-paired leiomyoma and normal myometrium. Screening up to 17 000 genes identified 21 upregulated and 50 downregulated genes. The gene-expression profiles were classified into mutually dependent 420 functional sets, resulting in 611 cellular processes according to the gene ontology. Also, protein analysis using two-dimensional gel electrophoresis identified 33 proteins (17 upregulated and 16 downregulated) of more than 500 total spots, which was classified into 302 cellular processes. Of these functional profilings, downregulations of transcriptomes and proteoms were shown in cell adhesion, cell motility, organogenesis, enzyme regulator, structural molecule activity and response to external stimulus functional activities that are supposed to play important roles in pathophysiology. In contrast, the upregulation was only shown in nucleic acid-binding activity. Taken together, potentially significant pathogenetic cellular processes were identified and showed that the downregulated functional profiling has a significant impact on the discovery of pathogenic pathway in leiomyoma. Also, the gene ontology analysis can overcome the complexity of expression profiles of cDNA microarray and two-dimensional protein analysis via its cellular process-level approach. Therefore, a valuable prognostic candidate gene with relevance to disease-specific pathogenesis can be found at cellular process levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14748746      PMCID: PMC2517572          DOI: 10.1111/j.0959-9673.2003.00362.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  34 in total

1.  Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.

Authors:  M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

2.  The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts.

Authors:  C C Chen; F E Mo; L F Lau
Journal:  J Biol Chem       Date:  2001-10-02       Impact factor: 5.157

3.  Overexpression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 decreases bone density in adult mice and induces dwarfism.

Authors:  T Nakanishi; T Yamaai; M Asano; K Nawachi; M Suzuki; T Sugimoto; M Takigawa
Journal:  Biochem Biophys Res Commun       Date:  2001-03-02       Impact factor: 3.575

4.  A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity.

Authors:  C Ploix; D Lo; M J Carson
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

Review 5.  Estrogen-associated genes in uterine leiomyoma.

Authors:  S Li; J A McLachlan
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

6.  Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells.

Authors:  R Salcedo; H A Young; M L Ponce; J M Ward; H K Kleinman; W J Murphy; J J Oppenheim
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

7.  Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5.

Authors:  P Ogilvie; G Bardi; I Clark-Lewis; M Baggiolini; M Uguccioni
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

Review 8.  Leiomyomata: heritability and cytogenetic studies.

Authors:  A H Ligon; C C Morton
Journal:  Hum Reprod Update       Date:  2001 Jan-Feb       Impact factor: 15.610

9.  The human MCP-2 gene (SCYA8): cloning, sequence analysis, tissue expression, and assignment to the CC chemokine gene contig on chromosome 17q11.2.

Authors:  E Van Coillie; P Fiten; H Nomiyama; Y Sakaki; R Miura; O Yoshie; J Van Damme; G Opdenakker
Journal:  Genomics       Date:  1997-03-01       Impact factor: 5.736

10.  Multiple leiomyomas of the esophagus, lung, and uterus in multiple endocrine neoplasia type 1.

Authors:  J L McKeeby; X Li; Z Zhuang; A O Vortmeyer; S Huang; M Pirner; M C Skarulis; L James-Newton; S J Marx; I A Lubensky
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

View more
  17 in total

1.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

2.  High expression of calcium channel subtypes in uterine fibroid of patients.

Authors:  Xiaoping Ke; Zhongping Cheng; Xiaoyan Qu; Hong Dai; Wenchao Zhang; Zi-Jiang Chen
Journal:  Int J Clin Exp Med       Date:  2014-05-15

3.  Fibroid-associated heavy menstrual bleeding: correlation between clinical features, Doppler ultrasound assessment of vasculature, and tissue gene expression profiles.

Authors:  Sophia E Tsiligiannis; Marina Zaitseva; Peter R Coombs; Paul Shekleton; Moshe Olshansky; Martha Hickey; Beverley Vollenhoven; Peter A W Rogers
Journal:  Reprod Sci       Date:  2012-09-20       Impact factor: 3.060

Review 4.  The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy.

Authors:  Reshef Tal; James H Segars
Journal:  Hum Reprod Update       Date:  2013-09-29       Impact factor: 15.610

5.  Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation.

Authors:  Erica N Nierth-Simpson; Melvenia M Martin; Tung-Chin Chiang; Lilia I Melnik; Lyndsay V Rhodes; Shannon E Muir; Matthew E Burow; John A McLachlan
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

Review 6.  The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma.

Authors:  Xiaoping Luo; Nasser Chegini
Journal:  Semin Reprod Med       Date:  2008-10-24       Impact factor: 1.303

7.  Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient.

Authors:  Irina K Dimitrova; Jennifer K Richer; Michael C Rudolph; Nicole S Spoelstra; Elaine M Reno; Theresa M Medina; Andrew P Bradford
Journal:  Fertil Steril       Date:  2008-07-30       Impact factor: 7.329

8.  Text-mining approach to evaluate terms for ontology development.

Authors:  Lam C Tsoi; Ravi Patel; Wenle Zhao; W Jim Zheng
Journal:  J Biomed Inform       Date:  2009-03-24       Impact factor: 6.317

9.  Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma.

Authors:  William H Catherino; Heba M Eltoukhi; Ayman Al-Hendy
Journal:  Semin Reprod Med       Date:  2013-08-09       Impact factor: 1.303

10.  Tumor Necrosis Factor-alpha- and interleukin-1-induced cellular responses: coupling proteomic and genomic information.

Authors:  Lee W Ott; Katheryn A Resing; Alecia W Sizemore; Joshua W Heyen; Ross R Cocklin; Nathan M Pedrick; H Cary Woods; Jake Y Chen; Mark G Goebl; Frank A Witzmann; Maureen A Harrington
Journal:  J Proteome Res       Date:  2007-05-16       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.